14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.25 $5.48 Wednesday, 1st May 2024 QURE stock ended at $4.57. This is 3.63% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 6.31% from a day low at $4.36 to a day high of $4.64.
90 days $4.25 $6.85
52 weeks $4.25 $22.48

Historical uniQure N.V. prices

Date Open High Low Close Volume
Aug 21, 2023 $8.66 $9.08 $8.63 $8.89 640 396
Aug 18, 2023 $8.26 $8.72 $8.20 $8.67 588 815
Aug 17, 2023 $8.53 $8.63 $8.26 $8.32 623 275
Aug 16, 2023 $8.85 $8.85 $8.47 $8.51 528 203
Aug 15, 2023 $8.60 $8.94 $8.55 $8.91 477 226
Aug 14, 2023 $8.44 $8.69 $8.25 $8.64 613 961
Aug 11, 2023 $8.52 $8.68 $8.46 $8.54 436 778
Aug 10, 2023 $8.58 $8.86 $8.52 $8.56 439 532
Aug 09, 2023 $8.62 $8.74 $8.40 $8.57 623 004
Aug 08, 2023 $8.84 $8.86 $8.52 $8.58 1 125 497
Aug 07, 2023 $9.46 $9.46 $8.91 $8.92 1 033 822
Aug 04, 2023 $9.69 $9.87 $9.36 $9.42 709 112
Aug 03, 2023 $10.06 $10.16 $9.54 $9.66 696 373
Aug 02, 2023 $10.38 $10.54 $10.02 $10.06 1 168 323
Aug 01, 2023 $10.44 $10.66 $10.15 $10.62 868 026
Jul 31, 2023 $9.92 $10.45 $9.90 $10.37 874 860
Jul 28, 2023 $9.59 $9.99 $9.51 $9.86 1 083 059
Jul 27, 2023 $9.50 $9.63 $9.33 $9.51 1 106 446
Jul 26, 2023 $9.51 $9.60 $9.40 $9.50 557 563
Jul 25, 2023 $9.70 $9.85 $9.47 $9.51 599 779
Jul 24, 2023 $10.00 $10.03 $9.65 $9.73 830 663
Jul 21, 2023 $10.03 $10.13 $9.75 $10.02 988 356
Jul 20, 2023 $10.26 $10.30 $9.93 $9.95 945 922
Jul 19, 2023 $10.59 $10.76 $10.26 $10.31 677 511
Jul 18, 2023 $10.62 $10.78 $10.55 $10.63 566 149
Click to get the best stock tips daily for free!

About uniQure N.V.

uniQure N.V. uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas... QURE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT